DECLARATIONS Authors contributions Controlled the study design and preparation of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Participated in planning and drafting the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Approved the final draft of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Availability of data and materials Not applicable
GHK-Cu differs from peptides like Matrixyl or Argireline in its biological activity and wound-healing properties
Request Your 30-Minute Preliminary Case Review 1
However, once steady state is reached, both forms produce equivalent therapeutic outcomes at their respective labeled doses
Given its pivotal physiological role, researchers have developed GLP-1 receptor agonists (GLP-1 RAs) through structural modifications
Abkarian, M